Besides, the currently available preclinical data indicates that TSG-6 can function as a potential antifibrotic and angiogenic agent and can regulate pro-inflammatory cytokines and enhance tissue repair in multiple animal models, while suppressing inflammatory reactions induced by ischemia in a variety of disease models (54, 65, 66, 91, 153). Here, TNFAIP6 is linked to ischemia.